Sign in

CIK 0001598646

  • Non-accelerated filer
  • Smaller reporting company

Minerva Neurosciences, Inc.

Sign in to watch
Ticker
NERV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
260784194
Phone
+1 617-600-7373
Business address
1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
  1. 4 Open-market sale CEO sold 2,412 shares at $7.10 ($17,125)
  2. 4 Open-market sale SVP, Chief Accounting Officer sold 1,557 shares at $7.10 ($11,055)
  3. 4 Open-market sale SVP & Chief Operating Officer sold 2,724 shares at $7.10 ($19,340)
  4. 4 Open-market sale President sold 3,113 shares at $7.42 ($23,098)
  5. 4 Open-market buy Director bought 3,500 shares at $5.50 ($19,250)
  6. 4 Open-market buy Director bought 10,000 shares at $5.37 ($53,700)
  7. 4 Open-market buy Director bought 1,000 shares at $5.25 ($5,250)
  8. 4 Open-market buy Director bought 10,000 shares at $5.60 ($56,000)
  9. 4 Open-market buy Director bought 10,000 shares at $5.55 ($55,500)
  10. 4 Open-market sale 10% owner sold 197,000 shares at $6.01 ($1,184,837)
  11. 4 Open-market sale 10% owner sold 110,818 shares at an average $4.41 ($488,911)
  12. 4 Open-market sale 10% owner sold 105,918 shares at an average $4.44 ($470,730)
  13. 4 Open-market sale 10% owner sold 78,467 shares at an average $4.51 ($353,737)
  14. 4 Open-market sale 10% owner sold 60,051 shares at an average $4.69 ($281,343)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 14 · 264 filings